SUMMARY Electrophysiological studies were performed in eight patients (four men and four women, mean (SD) age 24 (5) years with paroxysmal attacks of palpitation during or immediately after exercise. Five patients were competitive athletes at college. In two patients spontaneous supraventricular tachycardia during exercise was recorded by ambulatory electrocardiographic monitoring and in another it was induced by treadmill exercise testing. Two had dual atrioventricular nodal pathways, three had manifest atrioventricular accessory pathways, and three had concealed atrioventricular pathways. Programmed stimulation induced sustained supraventricular tachycardia in six patients-in two after intravenous injection of atropine sulphate (1 mg) and in four during infusion of isoprenaline (0-01 gg/kg/min). In one patient, non-sustained atrioventricular nodal reentrant tachycardia was induced during isoprenaline infusion. In the remaining patient, who had dual atrioventricular nodal pathways, tachycardia was not inducible. AH block prevented maintenance of reentry in five patients. In five patients shortening of the effective refractory period of the atrioventricular node with atropine (one patient) and isoprenaline (four patients) caused sustained supraventricular tachycardia.
It is widely accepted that well trained athletes tend to have bradycardia." Nevertheless, there are rare reports ofexercise related supraventricular tachycardia."4 Coelho et al reported various forms of tachycardia in young athletes, including five with paroxysmal supraventricular tachycardia.' We report the electrophysiological findings in eight patients with exercise related paroxysmal palpitation.
Patients and methods
We studied eight patients (four men and four women, Requests for reprints to Dr Iku Toda, The Second Departnent of Internal Medicine, University ofTokyo, 7-3-1, Hongo, Bunkyo-ku, Tokyo 113, Japan.
Accepted for publication 18 October 1988 mean (SD) age 24 (5) years) who were referred for electrophysiological study from October 1983 to September 1987 because of repeated paroxysms of palpitation during or immediately after physical exercise or both. Five of eight patients were competitive athletes at college. History taking, physical examination, 24 hour ambulatory electrocardiographic monitoring, and a symptom limited exercise test on a treadmill or ergometer were performed in all eight patients. We established that the paroxysms of palpitation were related to exercise, especially the intensity of exercise. The intensity of exercise was graded arbitrarily as follows: moderate = higher level of exercise than daily activity (for example warming up exercises); strenuous = actual training for competitive athletics (for example repeated trials of the 100 metre dash).
Exercise related paroxysmal ventricular tachycardia ELECTROPHYSIOLOGICAL STUDY Patients gave their informed consent to the electrophysiological study, which was performed while they were non-sedated and fasting. None of the patients had ever been treated with cardioactive drugs.
Three catheter electrodes (USCI 6F) were introduced percutaneously under fluoroscopic control into the femoral vein and positioned in the high right atrium, across the tricuspid valve for His bundle recording, and at the right ventricular apex. Left atrial potentials were recorded on an oesophageal lead (Medtronic IOF).9 Intracardiac potentials and the left atrial potential were filtered at 50-500 Hz and recorded simultaneously by leads I, aVF, and VI on an ink jet recorder at paper speeds of 50-100 mm/s. Analogue data were also recorded on magnetic tape for later analysis.
A digital programmable stimulator (Fukuda Denshi, BC02) was used to give programmed stimulation with 2 ms rectangular pulses that were 1-5 times diastolic threshold. Programmed stimulation was performed as follows: (a) extrastimulation (S2) was delivered from the high right atrium with a 10 ms reduction in the interval between stimuli every six sinus or atrial paced (Si) beats (the basic paced cycle lengths ranged from 750 to 400 ms); (b) incremental atrial pacing up basic cycle length identical to control in only two patients (1 and 4) . Isoprenaline shortened the sinus cycle from 1033 (140) ms to 523 (81) ms (p < 0-01). The effective refractory period ofthe atrioventricular node was shortened further by isoprenaline infusion in five patients, although basic pacing cycle lengths were shortened during infusion (see Discussion). Isoprenaline-induced changes in the effective refractory period of accessory pathway were determined at the basic cycle length identical to that during the control state in patient 6 only. Figure 2 shows a representative example of induction of supraventricular tachycardia by programmed stimulation in patient 4 whose spontaneous supraventricular tachycardia is shown in fig 1. In the control state, supraventricular tachycardia was not induced in any patient. In four patients, single atrial echo which did not propagate to the ventricle because of atriohisian block was induced with programmed stimulation.
When the eight patients were given intravenous atropine injection, sustained supraventricular tachycardia was induced in two and non-sustained supraventricular tachycardia in another two (table 1). In the two patients (cases 5 and 6), single atrial echo was also induced but did not propagate to the ventricle after atropine injection. Isoprenaline was then infused in six patients in whom sustained supraventricular tachycardia was not induced after atropine injection. During isoprenaline infusion, sustained supraventricular tachycardia was induced in four patients and non-sustained supraventricular tachycardia in one patient. Supraventricular tachycardia was not sustained because of an atriohisian block after atropine injection in two patients and during isoprenaline infusion in one patient. In patient 8, tachycardia was not induced even during isoprenaline infusion. In summary, sustained reentry was facilitated by shortening of the effective refractory period of the atrioventricular node by atropine in one patient (case 1) and by isoprenaline in four (cases 3, 4, 5, and 6). remaining seven patients were allowed to continue their athletic activities because their paroxysms of palpitation subsided as soon as exercise stopped.
Discussion
We found that atropine or isoprenaline was required to shorten the effective refractory period of the atrioventricular node for supraventricular tachycardia to be sustained in five of eight patients with paroxysms ofpalpitation related to exercise. Isoprenaline infusion was necessary to induce supraventricular tachycardia in those who had had episodes of palpitation during strenuous exercise. The basis for the arrhythmia included dual atrioventricular nodal pathways in two and manifest or concealed atrioventricular bypass in six of the eight patients. 
LIMITATIONS
The present study has several limitations. Firstly, only three of eight patients showed spontaneous arrhythmia. Therefore, the induced supraventricular tachycardia might not have been the cause of exercise related paroxysms ofpalpitation in the remaining five patients; none the less, four of them said that the palpitation that they experienced during induced tachycardia was similar to their exercise related palpitation. Secondly, comparison ofeffective refractory periods of the right atrium, atrioventricular node, and accessory pathway after drug injection was hampered by the different basic cycle lengths used. Additionally, the presence of an accessory pathway prevented precise determination of the effective refractory period of the atrioventricular node. Injection of atropine or isoprenaline, however, facilitated conduction via the atrioventricular node. The refractory period of the atrioventricular node is known to lengthen as the basic cycle length gets shorter.'6 A decrease of basic cycle length per se could shorten the right atrial effective refractory period'6 and might facilitate induction of supraventricular tachycardia by programmed stimulation. However, shortening of the effective refractory period of the atrioventricular node with atropine or isoprenaline provided an important basis for continued reciprocation. Thirdly, a treadmill or ergometer exercise test provoked supraventricular tachycardia in only one patient. This low rate of provocation of tachycardia with an exercise test might be because exercise was not as strenuous as that reported by Coelho et al. 6 Finally, the mechanism of palpitation in patient 8 remained uncertain. We should have tested a higher dose of isoprenaline infusion.
CLINICAL IMPLICATIONS
The present data and the results of Coelho et al6 show that an exercise test rarely induces supraventricular tachycardia in patients with exercise related
